Association between Cigarette Smoking and Hypoxanthine Guanine Phosphoribosyltransferase Activity

[1]  Y. Shim,et al.  Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. , 2003, Cancer research.

[2]  F. Gilliland,et al.  Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. , 2002, Cancer research.

[3]  John K. Wiencke,et al.  p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer , 2001 .

[4]  A. Buño,et al.  The Spectrum of Hypoxanthine-Guanine Phosphoribosyltransferase (HPRT) Deficiency: Clinical Experience Based on 22 Patients from 18 Spanish Families , 2001, Medicine.

[5]  M. Moeschberger,et al.  Cotinine levels in Southeast Asian smokers. , 2000, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[6]  G. Pershagen,et al.  Influence of smoking and donor age on the spectrum of in vivo mutation at the HPRT-locus in T lymphocytes of healthy adults. , 1999, Mutation research.

[7]  Y. Ko,et al.  Identification of a new single nucleotide substitution on the hypoxanthine-guanine phosphoribosyltransferase gene (HPRT(Tsou) from a Taiwanese aboriginal family with severe gout. , 1999, The Journal of rheumatology.

[8]  K. Hemminki,et al.  Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls. , 1999, Carcinogenesis.

[9]  E. Whorton,et al.  Frequencies of hprt mutant lymphocytes in marijuana-smoking mothers and their newborns. , 1998, Mutation research.

[10]  S. Hirohashi,et al.  DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. , 1997, Cancer research.

[11]  P. Kerstens,et al.  Purine enzyme activities in peripheral blood mononuclear cells: comparison of a new non-radiochemical high-performance liquid chromatography procedure and a radiochemical thin-layer chromatography procedure. , 1995, Journal of chromatography. B, Biomedical applications.

[12]  A. Tates,et al.  An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets. , 1994, Mutation research.

[13]  R. Albertini,et al.  Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. , 1994, Mutation research.

[14]  E. Whorton,et al.  Elevated frequencies of hprt mutant lymphocytes in cigarette-smoking mothers and their newborns. , 1994, Mutation research.

[15]  M. Passeri,et al.  Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. , 1993, Blood.

[16]  I. M. Jones,et al.  Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  T. Skopek,et al.  In vivo mutations in human blood cells: biomarkers for molecular epidemiology. , 1993, Environmental health perspectives.

[18]  R. Branda,et al.  Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. , 1993, Mutation research.

[19]  A. McLean,et al.  Lifespan of human lymphocyte subsets defined by CD45 isoforms , 1992, Nature.

[20]  T. Skopek,et al.  Molecular analyses of a Lesch-Nyhan syndrome mutation (hprtMontreal) by use of T-lymphocyte cultures , 1990, Human Genetics.

[21]  G. Nuki,et al.  Hypoxanthine-guanine phosphoribosyltransferase deficiency in three brothers with gout: Characterization of a variant, HPRTEdinburgh, having altered isoelectric point, increased thermal lability and normal levels of messenger RNA , 1989, Journal of Inherited Metabolic Disease.

[22]  B. Davidson,et al.  Human hypoxanthine-guanine phosphoribosyltransferase: a single nucleotide substitution in cDNA clones isolated from a patient with Lesch-Nyhan syndrome (HPRTMidland). , 1988, Gene.

[23]  B. Davidson,et al.  Identification of a single nucleotide change in a mutant gene for hypoxanthine-guanine phosphoribosyltransferase (HPRTAnn Arbor) , 1988, Human Genetics.

[24]  E. Whorton,et al.  Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study. , 1988, Mutation research.

[25]  E. Hook.  Perspectives in mutation epidemiology: 3. Contribution of chromosome abnormalities to human morbidity and mortality and some comments upon surveillance of chromosome mutation rates , 1983 .

[26]  J. Wilson,et al.  Human hypoxanthine (guanine) phosphoribosyltransferase: an amino acid substitution in a mutant form of the enzyme isolated from a patient with gout. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Crawhall,et al.  Diagnosis and Treatment of the Lesch-Nyhan Syndrome , 1972, Pediatric Research.

[28]  J. Seegmiller,et al.  A specific enzyme defect in gout associated with overproduction of uric acid. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Seegmiller,et al.  Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis , 1967, Science.

[30]  E. Mark,et al.  p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. , 2001, Cancer research.

[31]  A. Buño,et al.  The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. , 2000, Advances in experimental medicine and biology.

[32]  E. Whorton,et al.  Frequencies of hprt mutant lymphocytes in smokers, non‐smokers, and former smokers , 1997, Environmental and molecular mutagenesis.

[33]  J. Cole,et al.  International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. , 1994, Mutation research.

[34]  J. Seegmiller,et al.  Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Gout , 1969 .